Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-04-20 | By Order of the Board of Directors /s/ Justin Schreiber Justin Schreiber April 20, 2018 Chief Executive Officer and Director |
| 2019-12-16 | By Order of the Board of Directors /s/ Justin Schreiber Justin Schreiber December 16, 2019 Chief Executive Officer and Director |
| 2020-12-07 | Justin Schreiber Chief Executive Officer and Chairman of the Board of Directors December 7, 2020 The following summary compensation table indicates the cash and non-cash compensation earned from the Company during the years ended December 31, 2019 and 2018 by the current and former executive officers of the Company and each of the other two highest paid executives or directors, if any, whose total compensation exceeded $100,000 during those periods. Justin Schreiber 2019 - - 824,000 - - - 52,000 876,000 Mr. Schreiber was appointed a member of the Board on June 24, 2017. Mr. Schreiber became the Company’s President and Chief Executive Officer on February 2, 2018. |
| 2021-05-12 | Justin Schreiber – President, Chief Executive Officer and Chairman Mr. Schreiber was appointed President and CEO of Immudyne, Inc. upon the closing of the sale of the legacy beta glucan business in February 2018. Mr. Schreiber was appointed as Immudyne PR’s President on April 1, 2017. Mr. Schreiber is the President and founder of JLS Ventures, an investment and capital markets advisory firm that invests in and consults with emerging growth publicly-traded companies. Prior to founding JLS Ventures, Mr. Schreiber ran a consulting business that provided investor relations, advisory services and capital raising solutions to small publicly traded companies. In addition to his capital markets experience, Mr. Schreiber previously worked for a global healthcare consulting firm as well as in the foreign currency trading business. He holds a BS in International Business from Elizabethtown College and a BA in International Management from the ICN École de management in Nancy, France. We estimate that Mr. Schreiber spends approximately 90-100% of this time on the activities of the Company. The balance of his time is spent between his other entities. |
| 2022-04-29 | Justin Schreiber – Chief Executive Officer and Chairman of the Board\nMr. Schreiber has served as Chief Executive Officer of the Company since 2018, and formerly President of the Company from 2018 to 2021. Mr. Schreiber has been Chairman of the Board since 2019. |
| 2023-04-28 | Justin Schreiber – Chief Executive Officer and Chairman of the Board Mr. Schreiber has served as Chief Executive Officer of the Company and member of the Board of Directors since 2018, and formerly President of the Company from 2018 to 2021. Mr. Schreiber has been Chairman of the Board since 2019. |
| 2024-04-29 | Justin Schreiber – Chief Executive Officer and Chairman of the Board Mr. Schreiber has served as Chief Executive Officer of the Company and member of the Board of Directors since 2018, and formerly President of the Company from 2018 to 2021. Mr. Schreiber has been Chairman of the Board since 2019. |
Data sourced from SEC filings. Last updated: 2026-02-03